April 20, 2014 8:41 PM ET

Life Sciences Tools and Services

Company Overview of Sanford-Burnham Medical Research Institute

Executive Profile

John C. Reed M.D., Ph.D.

Head of Pharma Research & Early Development, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships
55--

Background

Dr. John C. Reed, M.D, Ph.D has been the Head of Pharma Research & Early Development at Roche Holding AG since April 2, 2013. He serves as an Assistant Professor, Department of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine. Dr. Reed is an Adjunct professor at the University of California San Diego (UCSD) Department of Molecular Pathology, University of Florida, University of Central Florida, and in San Diego State University's ...

Corporate Headquarters

10901 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-646-3100
Fax: 858-646-3199

Board Members Memberships

Co-founder and Member of Scientific Advisory Board
Member of Advisory Board
Former Director
2002-2013
Former Director
2004-N/A
Director, Member of Audit Committee, Member of Compensation Committee, and Member of Nominating Committee
2005-Present
Independent Director
2008-2009
Former Director, Member of Compensation & Option Committee and Member of Nominating & Corporate Governance Committee

Education

PhD 1986
The University of Pennsylvania
MD
The University of Pennsylvania
BA 1980
University of Virginia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$2.9M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
$3.1M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
$3.0M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sanford-Burnham Medical Research Institute, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.